Troglitazone has been demonstrated to exert a synergistic effect with tamoxifen in inducing growth inhibition, cell cycle arrest, and apoptosis in ERα-positive MCF-7 breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.